Trademark: 85443021
Status Date
Monday, May 4, 2015
Filing Date
Monday, October 10, 2011
Published for Opposition
Tuesday, February 7, 2012
Abandoned Date
Monday, May 4, 2015
5 Human pharmaceuticals for the treatment of anti-viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases
May 4, 2015
Abandonment Notice Mailed - No Use Statement Filed
May 4, 2015
Abandonment - No Use Statement Filed
Sep 30, 2014
Notice Of Approval Of Extension Request E-Mailed
Sep 29, 2014
Extension 5 Granted
Sep 23, 2014
Extension 5 Filed
Sep 23, 2014
Teas Extension Received
Apr 9, 2014
Notice Of Approval Of Extension Request E-Mailed
Apr 8, 2014
Extension 4 Granted
Mar 27, 2014
Extension 4 Filed
Mar 27, 2014
Teas Extension Received
Sep 26, 2013
Notice Of Approval Of Extension Request E-Mailed
Sep 25, 2013
Extension 3 Granted
Sep 16, 2013
Extension 3 Filed
Sep 16, 2013
Teas Extension Received
Apr 11, 2013
Notice Of Approval Of Extension Request E-Mailed
Apr 10, 2013
Extension 2 Granted
Mar 14, 2013
Extension 2 Filed
Apr 1, 2013
Case Assigned To Intent To Use Paralegal
Mar 14, 2013
Teas Extension Received
Mar 13, 2013
Teas Change Of Correspondence Received
Sep 20, 2012
Notice Of Approval Of Extension Request Mailed
Sep 18, 2012
Extension 1 Granted
Sep 18, 2012
Extension 1 Filed
Sep 18, 2012
Teas Extension Received
Apr 3, 2012
Noa Mailed - Sou Required From Applicant
Feb 7, 2012
Published For Opposition
Jan 18, 2012
Notice Of Publication
Jan 5, 2012
Law Office Publication Review Completed
Jan 3, 2012
Assigned To Lie
Dec 12, 2011
Approved For Pub - Principal Register
Dec 12, 2011
Assigned To Examiner
Oct 14, 2011
New Application Office Supplied Data Entered In Tram
Oct 13, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
